Karyopharm Therapeutics Inc. (KPTI) Capital expenditures 2016–2025
Karyopharm Therapeutics Inc. (KPTI) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$0FY2025 · since FY2016: $70,000 → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $0 | -100.0% |
| FY2024 | $142,000 | — |
| FY2023 | $0 | -100.0% |
| FY2022 | $118,000 | -44.3% |
| FY2021 | $212,000 | +46.2% |
| FY2020 | $145,000 | -29.6% |
| FY2019 | $206,000 | -91.3% |
| FY2018 | $2.4M | +3711.3% |
| FY2017 | $62,000 | -11.4% |
| FY2016 | $70,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice